Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemNext is a San Diego-based biotechnology company specializing in the application of stem cell biology and medicinal chemistry to drug discovery and development. Led by industry veteran Dr. Daniel D. Holsworth, the company focuses on therapeutic areas including dermatology, oncology, and regenerative medicine, with a particular emphasis on small molecule and peptide-based treatments. StemNext utilizes a fragment-based drug design platform to identify and optimize candidates for various indications such as hair loss, wound healing, and cancer. The firm has established strategic partnerships with CA Botana International and Molecular Botanicals to develop and commercialize innovative skin and hair care formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StemNext.